SYMBYX Biome announces closure

The pioneering medical technology company SYMBYX Biome has announced it is closing down after six years of developing innovative light therapies. As a cornerstone of photobiomodulation (light therapy) for the Parkinson's community, the company has actively pushed the boundaries of research by sponsoring several key clinical trials to investigate how red and infrared light can help manage symptoms. Their research focused heavily on the gut-brain axis, exploring how targeting the microbiome with non-invasive laser devices could stimulate cellular energy and improve both motor and non-motor symptoms. Through this work and a commitment to accessible science, the team became a strong, supportive voice for people living with the condition. The community will be incredibly sad to see them go, and we wish all the best to the entire team who worked so hard to bring complementary therapeutic options to light. For those who use or are considering their technology, the company has shared several key details regarding their closure: Website Closure: The last day to place new orders on the website is 23 July 2026, after which the online stores will close. Clearance Sale: To assist those looking to purchase before the closure, the SYMBYX Neuro helmet is currently available at a 25% discount. Warranty Support: Existing customers with a SYMBYX device are reassured that their 12-month product warranty remains fully valid and will continue as normal. Customer Support: For any warranty claims, device questions, or general support, the team remains reachable via email at info@symbyxbiome.com. Thank you to the SYMBYX team for their dedication to Parkinson's research and for playing such a valuable role in the global community over the last six years.